Lindsey’s practice focuses on regulatory law, keeping industry clients compliant with ever-changing rules and regulations. She also works with corporations and insurance companies on litigation regarding insurance coverage, product liability, and asbestos defense.
Regulatory and administrative law is a dynamic field, requiring agile navigation of the rules and regulations imposed by federal agencies including OSHA and FDA, as well as state and local-level agencies. Lindsey monitors the news and regularly attends national conferences, staying up-to-the-minute on the regulatory climate and industry developments. She has a natural facility for transforming complex information into understandable terms, and is often the first to blog about legal developments important to clients.
Lindsey sees cohesion between tenacious investigation, meticulous research, and persuasive writing, driving her to discover and unveil all accessible facts, even when they are difficult to unearth.
She excels at building a case with early legal analysis and fact development to craft a persuasive argument for prompt resolution of litigation matters. Strategically anticipating arguments, she writes concise, straightforward analyses for her clients. She adeptly organizes vast amounts of information to extrapolate the data necessary to develop case strategy and prepare cohesive legal arguments and motions.
In addition to her practice, Lindsey also manages the firm’s Law Clerk Program, and serves on the Board of Fundraising and Charitable Activities. She is an active in the ABA as a member of the Administrative Law and Regulatory Practice Section and as an editor-member of the Young Lawyers Division (YLD) Affiliate Blog. Lindsey was recently profiled as a young regulatory law superstar in the “2017 Next Generation Attorney Special Issue” of Attorney at Law.
- U.S. District Court, District of North Dakota (2017)
- U.S. District Court, District of Minnesota (2016)
- Minnesota (2016)
- Wisconsin (2015)
- J.D., cum laude, William Mitchell College of Law, St. Paul, Minnesota (2015)
- Post-Bacc. Paralegal Certificate Program, Hamline University, St. Paul, Minnesota (2009)
- B.A., University of Minnesota, Minneapolis, Minnesota (2008)
Honors and Awards
- Federal Bar Association (FBA)
- American Bar Association (ABA)
- Administrative Law and Regulatory Practice Section
- Minnesota State Bar Association (MSBA)
- Food, Drug & Device Law Section
- Minnesota Defense Lawyers Association (MDLA)
As part of the firm’s commitment to giving back to the community, Brownson • Norby attorneys Kristi Brownson and Robert Brownson began the new year by preparing and serving residents of Our Saviour’s Housing in Minneapolis on Friday, January 5, 2018. Our Saviour’s Housing serves homeless men and women with housing and meals. This work is especially vital during the Continue Reading
This month, Brownson • Norby, PLLC’s Regulatory Practice Group submitted two comments relative to FDA’s regulation Deeming Tobacco Products to be Subject to the Federal Food, Drug, and Cosmetic Act, as Amended by the Family Smoking Prevention and Tobacco Control Act; Regulations on the Sale and Distribution of Tobacco Products and Required Warning Statements for Tobacco Products, 21 CFR Parts Continue Reading
Today, December 14, 2017, FDA published a summary of its "major policy goals for 2018." Since the administration change, and since the addition Scott Gottlieb as FDA commissioner, in 2017, regulated agencies have seen a change in the direction of regulatory reform. This is due in part to the reinvigoration of the Congressional Review Act, but also can be attributed Continue Reading
Today, October 18, 2017, FDA updated its compliance deadlines to reflect a new extension for those manufacturers and importers "affected by recent natural disasters"--a list of such areas is provided on here. The deadline for those in the designated areas has been moved out six months: The deadline for submission of the ingredient listing for those in the designated areas has Continue Reading
At the end of 2016, the USDA published a final rule entitled “Enhancing Retailer Standards in the Supplemental Nutrition Assistance Program (SNAP).” See Federal Register This rule is aimed at “support[ing] healthy lifestyles for SNAP recipients”. Those retailers currently accepting SNAP benefits must adhere to the new requirements—the first of which goes into effect Monday, October 16, 2017—in order to continue accepting Continue Reading
Today, October 11, 2017, FDA published an updated version of its "Prohibition of Distributing Free Samples of Tobacco Products" guidance, which, sets its restrictions on free samples apart from many of its other rules and requirements by extending the prohibition to components and parts. (note, in many of its recent guidances, FDA has stated an intention not to extend enforcement of Continue Reading
The past few weeks have seen some activity at FDA relating to the Deeming Rule, which is of particular interest given the looming deadlines for submitting the Establishment Registration and Product Listing (9/30/2017) and the Ingredient Listing (11/8/2017). Of note is that FDA is seeking industry insights and participation, presumably in an effort to better inform FDA on the ENDS Continue Reading
The current Deeming Rule deadlines for ENDS products that were on the market August 8, 2016 or prior are as follows: November 8, 2017 - Deadline to submit ingredient listing Deadline to remove modified risk statements from packages (e.g. "low", "light", "mild", etc.) August 10, 2018 - Packaging requirements: Manufacturers and retailers must ensure their product packages and ads Continue Reading
On August 2, 2017, the Public Health Advisory Committee—a subcommittee of the Minneapolis City Council—approved an amendment to the 2015 Minneapolis ordinance that would restrict sales of all flavored tobacco products—notably, to now include menthol, mint and wintergreen tobacco products—to “tobacco product shops”. According to the committee, the amendment is necessary to “help dissuade young people from smoking and to Continue Reading
FDA has published its new compliance deadline chart, which sets forth the various new deadlines and to which entities such deadlines apply. The chart can be found here: FDA New Compliance Deadline Chart It further notes a clarification that: Retailers that mix and prepare e-liquids or create or modify vaporizers will be regulated as both retailers and manufacturers. Importers of tobacco Continue Reading
Last week FDA released a statement regarding its intent to postpone the forthcoming Deeming Rule deadlines for the ENDS community. Today, FDA updated its website to reflect these new deadlines: You can find the FDA statement here: FDA Web Statement
Today, US Representative Duncan Hunter (R-CA) introduced the "Cigarette Smoking Reduction and Electronic Vapor Alternatives Act". The Act provides various standards for vaping devices and e-liquid products, but most significantly, the Act would remove these devices from the current FDA deeming regulation designed for traditional tobacco products. If bill becomes law as it currently reads, then some or all of the Continue Reading
On Monday, January 30, 2017, the Seventh Circuit held unconstitutional certain parts of an Indiana law which regulated the manufacture of e-liquids sold in the State. Of the law, the court noted "[w]hat is remarkable, however, is the Act’s extensive regulation beyond the manufacture and sale of e-liquid solutions in Indiana." Consequently, because the reach of the law went so Continue Reading
FDA published its final rule clarifying what it considers to be the distinction between tobacco products, and products derived from tobacco that constitute a drug or device. This distinction is important because FDA has separate requirements and standards to which entities must adhere depending on whether they manufacture or sell tobacco products or they manufacture and sell drugs or devices. That said, Continue Reading
While FDA has postponed the deadline to submit Ingredient Listings from February 8, 2017 to June 2017, it has yet to act with regard to the Health Document Submissions requirement. That said, February 8, 2017 remains a critical date for manufacturers and importers of newly deemed tobacco products. The guidance provided by FDA provides that for this submission, FDA seeks Continue Reading
In a recent revision to the guidance on Ingredient Listings, FDA has postponed the deadline for the Ingredient Listing--which was previously due on February 8, 2017. However, FDA recognizes that some manufacturers of newly deemed products are not familiar with the forms for listing ingredients and, therefore, may need additional time to complete them accurately. In addition, we are aware Continue Reading
Today, December 9, 2016, FDA sent out a notification that the deadline for domestic manufacturers to submit Establishment Registration and Product Listing has been pushed back from December 31, 2016 and are now due June 30, 2017. This change has been formally noted in Revised Guidance published in November. See here for Revised Guidance "The guidance has been revised again to Continue Reading
A par 3 that turned out to be a par 6: The Winners: Team Bob Brownson & Tom Linnihan
On March 1, 2016, a significant change of the No-Fault rules regarding discovery became effective, which has the potential to both promote transparency in no-fault arbitrations, and curtail over-billing and abuse of the no-fault system. Under the newly amended Rule 12 of the Automobile Insurance Arbitration Rules, the Minnesota Rules of Civil Procedure now apply to discovery in arbitrations involving Continue Reading